Prognostic, oncogenic roles, and pharmacogenomic features of AMD1 in hepatocellular carcinoma
The present study indicates that AMD1 functions as a potential role in HCC progression and may serve as a therapeutic target in HCC. This study constructed a novel AMD1-related scoring system for predicting the prognosis and treatment responsiveness of patients with HCC, enabling the prediction of prognosis and identification of potential treatment targets.
Authors
- Yao Xiao (ORCID: https://orcid.org/0000-0002-4638-4148)
- Liping Yu (ORCID: https://orcid.org/0000-0003-3536-6427)
- Yan Zhou (ORCID: https://orcid.org/0000-0002-7732-6485)
- Yi Zhou (ORCID: https://orcid.org/0000-0003-2534-286X)
- Youliang Zhou
- Jiabin Hu
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Westlake University (CN)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1186/s12935-024-03593-x
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00